Loading…
Based on limited metadata, this warning letter was issued to Pharmacy Resources Incorporated, a pharmacy-related company, on March 1, 2018. While the specific violations cannot be determined due to unavailable subject line information and limited documentation, the letter indicates regulatory concerns significant enough to warrant FDA enforcement action. The warning addresses products or practices categorized as "Other," though the particular regulatory scope and issuing office details are not available in the provided metadata. To understand the specific violations and required corrective actions, the complete warning letter text would be necessary.